Agios Pharmaceuticals, Inc. - stock earnings
AGIO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -95.9 million USD | 7.1 million USD |
| 2023Q3 | -91.3 million USD | 7.4 million USD |
| 2023Q2 | -83.8 million USD | 6.7 million USD |
| 2023Q1 | -71.4 million USD | 5.6 million USD |
| 2022Q4 | 172.2 million USD | 4.3 million USD |
| 2022Q3 | -72.4 million USD | 3.5 million USD |
| 2022Q2 | -86.0 million USD | 5.6 million USD |
| 2022Q1 | -88.4 million USD | 832000 USD |
| 2021Q4 | -94.6 million USD | 41 USD |
| 2021Q3 | -88.8 million USD | ? USD |
| 2021Q2 | -86.2 million USD | 37.3 million USD |
| 2021Q1 | 1.9 billion USD | 41.4 million USD |
| 2020Q4 | -97.7 million USD | 44.0 million USD |
| 2020Q3 | -99.0 million USD | 34.7 million USD |
| 2020Q2 | -90.5 million USD | 37.3 million USD |
| 2020Q1 | -40.3 million USD | 87.1 million USD |
| 2019Q4 | -102.4 million USD | 35.4 million USD |
| 2019Q3 | -106.2 million USD | 26.0 million USD |
| 2019Q2 | -109.9 million USD | 26.2 million USD |
| 2019Q1 | -93.1 million USD | 30.2 million USD |
| 2018Q4 | -91.8 million USD | 30.0 million USD |
| 2018Q3 | -94.7 million USD | 15.2 million USD |
| 2018Q2 | -68.7 million USD | 40.4 million USD |
| 2018Q1 | -90.8 million USD | 8.8 million USD |
| 2017Q4 | -88.3 million USD | 9.8 million USD |
| 2017Q3 | -77.1 million USD | 11.4 million USD |
| 2017Q2 | -83.1 million USD | 11.3 million USD |
| 2017Q1 | -66.2 million USD | 10.5 million USD |
| 2016Q4 | -56.5 million USD | 22.6 million USD |
| 2016Q3 | -62.8 million USD | 9.0 million USD |
| 2016Q2 | -56.0 million USD | 7.0 million USD |
| 2016Q1 | -23.2 million USD | 31.3 million USD |
| 2015Q4 | -40.6 million USD | 6.2 million USD |
| 2015Q3 | -40.3 million USD | 5.5 million USD |
| 2015Q2 | -31.9 million USD | 13.2 million USD |
| 2015Q1 | -5.0 million USD | 34.2 million USD |
| 2014Q4 | -26.7 million USD | 14.6 million USD |
| 2014Q3 | 3.7 million USD | 33.9 million USD |
| 2014Q2 | -18.3 million USD | 8.4 million USD |
| 2014Q1 | -12.2 million USD | 8.4 million USD |
| 2013Q4 | -12.4 million USD | 6.7 million USD |
| 2013Q3 | -11.2 million USD | 6.3 million USD |
| 2013Q2 | -8.6 million USD | 6.3 million USD |
| 2013Q1 | -7.2 million USD | 6.3 million USD |
| 2012Q4 | -5.3 million USD | 6.3 million USD |
| 2012Q3 | -4.6 million USD | 6.3 million USD |
| 2012Q2 | -5.5 million USD | 6.3 million USD |
| 2012Q1 | -4.6 million USD | 6.3 million USD |
| 2011Q4 | ? USD | 21.8 million USD |
AGIO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -352.1 million USD | 26.8 million USD |
| 2022 | -74.6 million USD | 14.2 million USD |
| 2021 | 1.6 billion USD | 41409 USD |
| 2020 | -335.2 million USD | 203.2 million USD |
| 2019 | -396.6 million USD | 117.9 million USD |
| 2018 | -346.0 million USD | 94.4 million USD |
| 2017 | -314.7 million USD | 43.0 million USD |
| 2016 | -198.5 million USD | 69.9 million USD |
| 2015 | -117.7 million USD | 59.1 million USD |
| 2014 | -53.5 million USD | 65.4 million USD |
| 2013 | -39.4 million USD | 25.5 million USD |
| 2012 | -20.1 million USD | 25.1 million USD |
| 2011 | -23.7 million USD | 21.8 million USD |
AGIO
Price: $31.49
52 week price:
Earnings Per Share: -6.33 USD
P/E Ratio: -5.89
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 44002
Ebitda: -88.5 millionMarket Capitalization: 1.6 billion